Ana de Barros, PhD, managing science editor —

Diabetes and high blood sugar were associated with elevated levels of neurofilament light (NfL) — a biomarker of nerve cell damage — and worse cognitive function among people with Parkinson’s disease, according to a recent study. “Our study is the first to show that diabetes and [a measure of…

A four-man crew from Britain is hoping to increase understanding of Parkinson’s disease by rowing across the Indian Ocean in an attempt to break a world record. Robin Buttery, Barry Hayes, James Plumley, and skipper Billy Taylor are planning to row for 1,920 hours non-stop, for 65 days straight, all…

The People with Parkinson’s Advisory Council of the Parkinson’s Foundation has five new members. The council is made of people living with Parkinson’s disease and their caregiver partners who contribute with their personal perspectives and experience to ensure that all the foundation’s programs and services are based on real-world needs…

Laurie Mischley, PhD, a researcher at the private, non-profit Bastyr University, is launching the first-ever summer school program for Parkinson’s disease patients. This August, Mischley will facilitate two medical-educational retreats at Bastyr as part of the new “PD Summer School.” Until June 15 those interested can apply…

European experts have developed a set of technology-based solutions for the early detection of Parkinson’s disease and improvement of patients’ quality of life. Led by Greek researchers at the Aristotle University of Thessaloniki, the four-year i-PROGNOSIS (Intelligent Parkinson eaRly detectiOn Guiding NOvel Supportive InterventionS) project is testing its first product…

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) recently awarded Alkahest a grant to support the development of ALK4290 as a new therapy for Parkinson’s disease. The immune system plays an important role in the development and progression of Parkinson’s disease. New therapies targeting the recruitment…

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and Verily Life Sciences are collaborating to collect data on movement, physiological, and environmental measures in Parkinson’s patients for the MJFF-led Parkinson’s Progression Markers Initiative (PPMI). More than 800 PPMI participants will be outfitted with Verily’s investigational Study Watch, a multi-sensor…

Worldwide Clinical Trials and Datavant have teamed up to improve research and clinical trial design for neurodegenerative diseases like Parkinson’s disease. The collaboration will combine Worldwide’s expertise in neurodegenerative diseases and clinical trial regimens with Datavant’s experience in organizing and structuring healthcare data. It intends to study…

e-Therapeutics recently entered a collaboration agreement with C4X Discovery to identify new intervention strategies for the treatment of Parkinson’s disease. The collaboration is based on leveraging e-Therapeutics’ Network-Driven Drug Discovery (NDD) platform for drug discovery with C4X Discoveries’ Taxonomy3 technology to identify new cellular mechanisms that are important…

The Michael J. Fox Foundation (MJFF) and the Edmond J. Safra Philanthropic Foundation recently awarded five new medical centers with funding to train clinician-researchers working with Parkinson’s disease and other movement disorders. The five centers, awarded at the fourth round of fellowship funding, will receive financial assistance through a…